Author

Alberte Wollesen Breum

University of CopenhagenORCID 0000-0002-8399-4308Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Andreas Mæchel FritzeniD· 1 shared Charlotte SvendseniD· 1 shared Christoffer ClemmenseniD· 1 shared Jens Teglgaard LundiD· 1 shared Kasper Suhr JørgenseniD· 1 shared Katrine T.-B. G. SchjoldageriD· 1 shared María J Romero-LadoiD· 1 shared Rebecca Louise MilleriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Andreas Mæchel FritzenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic and preclinical evidence implicating chondroitin sulfate as a matritherapeutic target for the treatment of type 2 diabetes

Valdemar Brimnes Ingemann Johansen, Jens Teglgaard Lund, María J Romero-Lado, Alberte Wollesen Breum, Charlotte Svendsen, Kasper Suhr Jørgensen, Rebecca Louise Miller, Andreas Mæchel Fritzen, Tuomas O. Kilpeläinen, Katrine T.-B. G. Schjoldager, Christoffer Clemmensen

This study identifies chondroitin sulfate as a potential therapeutic target for type 2 diabetes through genetic and preclinical evidence showing its effects on glycemic control and insulin action.

bioRxiv · Nov 12, 2025 · PreprintPhysiology